Soru

A 55-year-old woman is preparing for discharge following an admission for a non-ST-segment elevation myocardial infarction (NSTEMI). She underwent a successful percutaneous coronary intervention with the placement of a drug-eluting stent. Her past medical history includes hypertension and hyperlipidemia. Her vitals are temperature $37.0^\circ\text{C}$ ($98.6^\circ\text{F}$), blood pressure $122/78\text{ mmHg}$, pulse $68/\text{min}$, and respiratory rate $14/\text{min}$. An echocardiogram demonstrates a left ventricular ejection fraction of $55\%$. In addition to dual antiplatelet therapy with aspirin and clopidogrel, which of the following pharmacologic interventions should be included in her discharge regimen to provide a long-term mortality benefit? (Select all that apply)